Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype. Naselsky W, Adhikary G, Shrestha S, Chen X, et al. Mol Carcinog 2022;61:537-548.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Naselsky W, Adhikary G, Shrestha S, Chen X, et al. Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype. Mol Carcinog 2022;61:537-548.
PMID: 35319795